• Home
  • The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research.

The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research.

Author List
Leone FT, Mauger EA, Peters SP, Chinchilli VM, Fish JE, Boushey HA, Cherniack RM, Drazen JM, Fahy JV, Ford J, Israel E, Lazarus SC, Lemanske RF, Martin RJ, McGeady SJ, Sorkness C, Szefler SJ, Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute
Publication
Chest
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1422782
Publication Year
2001
PubMed ID
11296165
Publication Title
Leone FT, Mauger EA, Peters SP, Chinchilli VM, Fish JE, Boushey HA, Cherniack RM, Drazen JM, Fahy JV, Ford J, Israel E, Lazarus SC, Lemanske RF, Martin RJ, McGeady SJ, Sorkness C, Szefler SJ, Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research. Chest. 2001 Apr; 119(4):1027-33.